Phases, stages, and risk factors - considering new immunosuppresive strategies for renal transplant patients

Refer a Colleague

We invite you to Email a colleague and refer them to this program on renal transplantation.

Please fill out your colleague’s name and Email address in the spaces below to have an Email sent to them.

Please email one colleague at a time using this form.

This webcast was produced by the Supplement Division of Elsevier. Editorial support was supplied by Synergy, a medical education company, Richmond Surrey, U.K. Support for this webcast was provided by Wyeth Pharmaceuticals. The opinions expressed in this program are those of the faculty and do not necessarily reflect the views of Synergy, Wyeth Pharmaceuticals or of Elsevier.

Copyright ©2009 Elsevier Inc. All rights reserved. No part of this program may be reproduced or transmitted in any form, by any means, without prior written permission of the Publisher. Elsevier Inc. will not assume responsibility for damages, loss, or claims of any kind arising from or related to the information contained in this publication, including any claims related to the products, drugs, or services mentioned herein.